Does Dr. THOMAS CLINCH have financial conflicts of interest?

Dr. THOMAS CLINCH (MD) has received a total of $18,513 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $18,513 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. THOMAS CLINCH?

According to CMS Open Payments data, Dr. THOMAS CLINCH received funding from JOHNSON & JOHNSON SURGICAL VISION ($15,742), ALCON VISION ($1,404), and NOVARTIS PHARMACEUTICALS CORPORATION ($273).

Does Dr. THOMAS CLINCH receive research grants or speaking fees?

Dr. THOMAS CLINCH has received $18,513 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. THOMAS CLINCH

MDReal-Time Hydrated

Specialty: Ophthalmology

Practice Location: CHEVY CHASE, MD 20815

NPI Number: 1437186350

LIFETIME INDUSTRY VALUE

$18,513

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. CLINCH is a verified Ophthalmology practitioner based in CHEVY CHASE, MD.

Between 2021 and 2025, Dr. CLINCH had an overall industry promotional and research financial footprint of $18,513 as recorded in the federal CMS Open Payments database.

$18,513 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. CLINCH's primary funding source is JOHNSON & JOHNSON SURGICAL VISION, which accounts for $15,742 (representing 85% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JOHNSON & JOHNSON SURGICAL VISION

Rank 1

$15,742

85%

ALCON VISION

Rank 2

$1,404

7.6%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$273

1.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.